Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Sample holder and method for treating sample material
Cardiac chamber volume computation from contours and base plane in cardiac MR Cine images
Maesa japonica extracts and methods of use
Adaptive switch mode LED system
Method and structure for adding mass with stress isolation to MEMS structures
Systems and methods for managing policies on a computer
Analysis device and an analysis apparatus using the analysis device
  Randomly Featured Patents
Method of restraining an amorphous metal core
Method and device for automatically detecting collimation edges
Rotor cover for motorcycles
Monodisperse telechelic amine-based polyureas for use in golf balls
Gesture-based commands for a group communication session on a wireless communications device
Pet water saver
Fastener or the like
Method and apparatus to reply to call
Force sensor with attached mass
Bulkhead socket for a co-axial plug and socket connector